Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker

Affiliations

• ¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ² Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ³ Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ⁴ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: jelee@mdanderson.org.